A culture committed to putting patients first
Vice President & Managing Director, Australia & New Zealand
Tom Karalis assumed the role of Vice President & Managing Director of Australia and New Zealand in August 2017 with responsibility for Celgene’s commercial operations in the region.
Tom joined Celgene in 2011 as Director, Strategic Marketing, Asia Pacific and in 2013 assumed the role of General Manager, East Asia, a geography comprising of South Korea, Taiwan, Singapore, Hong Kong, Thailand and Malaysia. Tom first joined the pharmaceutical industry in Australia with Pharmacia, gaining experience in multiple commercial roles with increasing levels of organizational and portfolio responsibility before moving to Hong Kong as Regional Marketing Director, Asia Pacific and to South Korea as Commercial Director. Further assignments in the Asia Pacific region included General Management roles in Thailand, Vietnam and Philippines before returning to Australia to join Celgene.
Senior Finance Director, Australia & New Zealand
Darren Hunt has been with Celgene since 2007. Prior to becoming Senior Finance Director, ANZ, Darren oversaw the finance operations of APAC for a period of 4 years. He also spent two years in the US at Celgene Headquarters based in New Jersey which involved working on the integration teams for both Gloucester Pharmaceuticals and Abraxis Bioscience acquisitions.
From 2001 to 2007 Darren was the Finance Manager for PlantTech Pty Ltd which operated in the agricultural business. Prior to 2001 Darren worked for Iveco Trucks in numerous finance roles over a period of 12 years, including the last two years as the Financial Controller of Truckline Pty Ltd.
Darren attended Deakin University, where he completed his Bachelor of Business, Accounting in 1994. He also is a member of CPA Australia.
Senior Director, Human Resources
Mafalda Lou joined Celgene in January 2011 as Senior Director Human Resources and built our HR function within the Asia Pacific region from inception.
Mafalda has over 30 year’s experience in Human Resources Management and leadership. Her career to date has been predominantly in the Healthcare industry, including Clinical Diagnostics, Biotechnology, Medical Devices and Pharmaceutical companies such as Johnson and Johnson, Vision Systems (now known as Leica Sytems), and Dorevitch Pathology. Included in the portfolio of companies Mafalda has served are a mixture of start -up companies through to large multinational companies, where her responsibilities also ranged from Global through to Regional leadership roles. Mafalda also has extensive international experience having worked abroad for a several years in the USA, UK and Singapore.
Calvin London, PhD
Head Business Operations & Integrity, Australia & New Zealand
Calvin London joined Celgene in January 2011 as Director, Scientific Affairs, Asia Pacific (APAC). He was promoted to Snr. Director, HCC & GxP Compliance, APAC in 2014. In these roles he was responsible for the design and implementation of the Good Affiliate Practice quality management systems and healthcare compliance systems across APAC, co-development of the RMP platform for APAC and management of different functions regionally.
Calvin has over 35 years international experience in the pharmaceutical, biological and biotechnology industry, specializing in the technical development, regulatory, quality and compliance management at an executive level. He has worked with several companies in the design, implementation and auditing of operating systems for quality and compliance to meet the requirements of regulatory agencies in the US, Europe and Australia. He has previously held different Board positions, technical roles of increasing responsibility associated with the development, manufacture and compliance of international products’ including the positions of Chief Operating Officer Argus Biomedical Pty Ltd and Chief Executive Officer for an international biotechnology company.
Senior Manager – Sales, Australia & New Zealand
Jacinta has worked in the pharmaceutical industry since 1994, starting her career at Boehringer Ingelheim (4yrs) and Merck Sharp & Dohme (13yrs) prior to joining Celgene March 2010. The majority of her career has been in specialist sales, with a strong focus in the field of Haematology/Oncology. At Celgene she has managed the National Sales Haematology team, held the position of Area Manager NZ and more recently developed experience in marketing in both Australia and New Zealand.
Jacinta attended Monash University where she completed a Bachelor of Science, she has also completed the Advanced Leadership Program with Women Leadership Australia.
Senior Manager – Marketing, Australia & New Zealand
Rob Williams joined Celgene in 2012 and moved into his current role, Senior Marketing Manager ANZ three years later in 2015. He started as the Myeloid Product Manager for ANZ, focused on Vidaza and also launched the niche Revlimid MDS 5q- indication. He now heads up the HaemOnc Marketing Team focused on the in-market haematology products and near to market indications/products coming through.
Rob’s career in pharmaceutics has spanned Novartis, Hospira and now Celgene over the past 16 years. He has undertaken numerous leadership roles across several therapeutic areas prior to Celgene including Regional Sales Manager for Victoria and New Zealand in the Oncology and Haematology space, National Sales Manager Australia in Urolology and Product Manager in Intensive Care and Anaesthetics.
Rob completed his Master of Business Administration (MBA) through Mt Eliza Business School in 2005 and is the founder and steering group member of Melbourne Pharma Marketers, an industry networking group.
Senior Manager, Strategic Planning, Australia & New Zealand
Alex Simpson joined Celgene in August 2009. Alex joined Celgene in a marketing role for myelodysplastic syndrome (MDS) products where he was responsible for the successful launch of Celgene’s local MDS portfolio. After 2 years Alex took on the marketing of the myeloma franchise allowing him exposure to Celgene’s full range of haematology products. During this time Alex had the opportunity to oversee several haematology market access projects for both Australia and New Zealand.
In 2013 he moved into the Australian Immunology and Inflammation Franchise as part of the start-up team.
He is currently setting up the cross franchise Strategic Planning function within Australia.
Dirk Hoenemann, MD
Medical Director, Australia & New Zealand
Dirk has approximately 10 years’ experience in experimental and clinical Haematology and Oncology. His academic appointments included the Humboldt University and Max Delbrueck Center for Molecular Medicine in Berlin, the Peter MacCallum Cancer Centre in Melbourne and the University of Wuerzburg in Germany. Through his academic experience he acted as investigator on numerous clinical trials from phase I to phase III. Prior to joining Celgene in 2010 he acted as Head of Medical Affairs for GSK Oncology in Australia.
Amanda McPherson, PhD
Director of Government Affairs and Market Access, Australia & New Zealand
Amanda has 15 year experience in Market Access and Corporate Affairs. Amanda has held various appointments within pharmaceutical and the biotechnology industries as well as working in consultancy. Amanda has been at Celgene for 5 years, in her prior position Amanda was co-lead of the pharmaceutical business and member of the Health Economics and Social Policy leadership team at Deloitte Access Economics.
Amanda has worked for BMS, Johnson and Johnson and M-TAG . Amanda holds a PhD in immunology from Monash University and has had extensive training in Health Outcomes and Health Economics throughout her working career including York University UK.
For Global Leadership, please visit the Corporate Website Leadership page.